David Frame

2.0k total citations
56 papers, 873 citations indexed

About

David Frame is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, David Frame has authored 56 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 14 papers in Oncology and 13 papers in Public Health, Environmental and Occupational Health. Recurrent topics in David Frame's work include Acute Lymphoblastic Leukemia research (13 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Acute Myeloid Leukemia Research (10 papers). David Frame is often cited by papers focused on Acute Lymphoblastic Leukemia research (13 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Acute Myeloid Leukemia Research (10 papers). David Frame collaborates with scholars based in United States, United Kingdom and Switzerland. David Frame's co-authors include Nasir Rana, Anat R. Tambur, Donald P. Braun, W. Paul Dmowski, Howard M. Gebel, John E. Levine, Daniel Kaul, Shin Mineishi, Michael R. Savona and Duane W. Newton and has published in prestigious journals such as Blood, CHEST Journal and Frontiers in Immunology.

In The Last Decade

David Frame

51 papers receiving 847 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Frame United States 16 242 205 200 180 135 56 873
François Montestruc France 15 279 1.2× 77 0.4× 126 0.6× 12 0.1× 99 0.7× 41 967
Elliott Perlin United States 17 225 0.9× 219 1.1× 107 0.5× 24 0.1× 79 0.6× 58 912
Türkiz Gursel Türkiye 17 96 0.4× 558 2.7× 111 0.6× 14 0.1× 115 0.9× 66 953
Amanda M. Eudy United States 17 50 0.2× 37 0.2× 346 1.7× 48 0.3× 52 0.4× 87 913
Juntao Liu China 20 86 0.4× 27 0.1× 181 0.9× 24 0.1× 110 0.8× 84 1.5k
S Barocci Italy 16 54 0.2× 27 0.1× 249 1.2× 48 0.3× 31 0.2× 53 693
José Luís Poveda Spain 18 199 0.8× 160 0.8× 63 0.3× 10 0.1× 72 0.5× 90 922
Mirosław Banasik Poland 18 33 0.1× 61 0.3× 398 2.0× 24 0.1× 33 0.2× 124 1.3k
Colin Broom United States 11 338 1.4× 19 0.1× 35 0.2× 427 2.4× 386 2.9× 17 1.2k
Hasmukh Patel United States 10 153 0.6× 127 0.6× 32 0.2× 31 0.2× 68 0.5× 24 842

Countries citing papers authored by David Frame

Since Specialization
Citations

This map shows the geographic impact of David Frame's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Frame with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Frame more than expected).

Fields of papers citing papers by David Frame

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Frame. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Frame. The network helps show where David Frame may publish in the future.

Co-authorship network of co-authors of David Frame

This figure shows the co-authorship network connecting the top 25 collaborators of David Frame. A scholar is included among the top collaborators of David Frame based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Frame. David Frame is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zuo, Yu, Erin Sandford, Gen Li, et al.. (2024). Longitudinal plasma proteomics in CAR T–cell therapy patients implicates neutrophils and NETosis in the genesis of CRS. Blood Advances. 8(6). 1422–1426. 2 indexed citations
2.
Zhao, Qiuhong, Chenyu Lin, Monalisa Ghosh, et al.. (2024). Siltuximab for chimeric antigen receptor T-cell therapy–related CRS and ICANS: a multicenter retrospective analysis. Blood Advances. 9(1). 170–175. 12 indexed citations
3.
Frame, David, Sarah Anand, Sung Won Choi, et al.. (2024). Comparing 2-day vs 3-day flu-CY lymphodepleting regimens for CD19 CAR T-cell therapy in patients with non-hodgkin’s lymphoma. Frontiers in Immunology. 15. 1403145–1403145. 5 indexed citations
4.
Lau, Benison, et al.. (2023). Hemophagocytic Lymphohistiocytosis as a Presenting Sign of Neuroblastoma. Clinical Immunology. 250. 109415–109415.
5.
6.
Frame, David, Thomas Braun, Mary Maliarik, et al.. (2022). Defibrotide Therapy for SARS-CoV-2 ARDS. CHEST Journal. 162(2). 346–355. 11 indexed citations
7.
Walkovich, Kelly, Nadine Saad, Mark Hannibal, et al.. (2022). SOCS1 Haploinsufficiency Presenting as Severe Enthesitis, Bone Marrow Hypocellularity, and Refractory Thrombocytopenia in a Pediatric Patient with Subsequent Response to JAK Inhibition. Journal of Clinical Immunology. 42(8). 1766–1777. 15 indexed citations
8.
9.
Connelly, James A., Hey Chong, Adam J. Esbenshade, et al.. (2021). Impact of COVID-19 on Pediatric Immunocompromised Patients. Pediatric Clinics of North America. 68(5). 1029–1054. 16 indexed citations
10.
Magenau, John, Thomas Braun, Pavan Reddy, et al.. (2015). Allogeneic transplantation with myeloablative FluBu4 conditioning improves survival compared to reduced intensity FluBu2 conditioning for acute myeloid leukemia in remission. Annals of Hematology. 94(6). 1033–1041. 8 indexed citations
11.
Marini, Bernard L., et al.. (2014). Treatment of Dyslipidemia in Allogeneic Hematopoietic Stem Cell Transplant Patients. Biology of Blood and Marrow Transplantation. 21(5). 809–820. 15 indexed citations
12.
Chang, Lawrence, David Frame, Thomas Braun, et al.. (2014). Engraftment Syndrome after Allogeneic Hematopoietic Cell Transplantation Predicts Poor Outcomes. Biology of Blood and Marrow Transplantation. 20(9). 1407–1417. 55 indexed citations
13.
14.
Frame, David, et al.. (2009). High Budesonide Bioavailability In Patients With Gastro-Intestinal (GI) Graft Versus Host Disease (GVHD) AND/OR Clostridium Difficile Infection. Biology of Blood and Marrow Transplantation. 15(2). 133–133. 1 indexed citations
15.
Savona, Michael R., Duane W. Newton, David Frame, et al.. (2007). Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant. Bone Marrow Transplantation. 39(12). 783–787. 83 indexed citations
16.
Frame, David. (2007). Introduction: Optimizing Outcomes Through Pharmaceutical Advances in the Treatment of Chronic Myeloid Leukemia. Journal of Managed Care Pharmacy. 13(8 Supp B). 2–3. 2 indexed citations
17.
Frame, David, et al.. (2004). Human Skeletal Allograft Collection — Room for Improvement?. Scottish Medical Journal. 49(4). 146–148. 4 indexed citations
18.
Raptis, Anastasios, et al.. (1999). Intravesicular instillation of E-aminocaproic acid for patients with adenovirus-induced hemorrhagic cystitis. Bone Marrow Transplantation. 24(11). 1259–1260. 19 indexed citations
19.
Gebel, Howard M., Donald P. Braun, Anat R. Tambur, et al.. (1998). Spontaneous Apoptosis of Endometrial Tissue is Impaired in Women with Endometriosis. Fertility and Sterility. 69(6). 1042–1047. 189 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by François Montestruc Breakdown of academic impact, for papers by Elliott Perlin Breakdown of academic impact, for papers by Türkiz Gursel Breakdown of academic impact, for papers by Amanda M. Eudy Breakdown of academic impact, for papers by Juntao Liu Breakdown of academic impact, for papers by S Barocci Breakdown of academic impact, for papers by José Luís Poveda Breakdown of academic impact, for papers by Mirosław Banasik Breakdown of academic impact, for papers by Colin Broom Breakdown of academic impact, for papers by Hasmukh Patel
Rankless by CCL
2026